Role of global assays in thrombosis and thrombophilia

doi:10.1017/CBO9781139028882.012

Chapter 11 - Role of global assays in thrombosis and thrombophilia

from Section 2 - Special considerations in pediatric patients

Published online by Cambridge University Press: 18 December 2014

Meera Chitlur and

Mindy L. Simpson

Edited by

Neil A. Goldenberg and

Marilyn J. Manco-Johnson

Show author details

Meera Chitlur: Affiliation:
Wayne State University
Mindy L. Simpson: Affiliation:
Rush University Medical Center, Chicago
Neil A. Goldenberg: Affiliation:
The Johns Hopkins University School of Medicine
Marilyn J. Manco-Johnson: Affiliation:
Hemophilia and Thrombosis Center, University of Colorado, Denver

Book contents

Get access

Summary

Introduction

Hemostasis is a complex process and is difficult to monitor in its entirety. Many laboratory tests have been developed to discern specific parts of the coagulation process in an attempt to diagnose disorders such as a tendency toward bleeding or clotting abnormally, and/or to predict clinical outcomes in these disorders. Because an in vitro test is simply a model of an in vivo process, it is important to understand what each test is measuring and its limitations. Traditional clotting assays such as the prothrombin time (PT) and activated partial thromboplastin time (APTT) measure the time for initiation of clot formation when, following initiation of coagulation in plasma via differing activators (PT: “thromboplastin,” comprised of tissue factor and phospholipid; APTT: “partial thromboplastin,” comprised of phospholipid without tissue factor), thrombin mediates the conversion of fibrinogen to fibrin. The endpoint of the PT and APTT occurs when only approximately 5% of thrombin has been produced [1]. PT and APTT also do not provide information regarding the rate and extent of clot formation, nor lytic function. As for other global tests, they are non-specific assays and, for abnormal test results, further testing is generally warranted to evaluate causality. Specific testing may include factor assays to evaluate for a factor deficiency or antibody testing to assess for inhibitory antibodies. The need for improved testing of hemostasis has been long recognized but an accepted standardized test is not yet widely available.

Thrombophilic states and the propensity toward thrombosis are difficult to diagnose/predict with laboratory assays. Testing for thrombophilia can be cumbersome, generally requiring testing for individual abnormalities, and may be difficult with smaller patients due to the amount of blood required for comprehensive testing. There is a need for improved thrombophilia/thrombosis testing and monitoring. Global assays attempt to better define the complete course of clot formation and breakdown through avenues such as the measurement of thrombin generation, fibrin formation, plasmin generation, and clot dissolution. Through a more complete picture of the hemostatic process, global assays may fill the gaps in knowledge regarding hemostatic abnormalities.

Information

Type: Chapter
Information: Pediatric Thrombotic Disorders , pp. 142 - 157

DOI: https://doi.org/10.1017/CBO9781139028882.012 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Brummel, KE, Paradis, SG, Butenas, S, Mann, KG. Thrombin functions during tissue factor-induced blood coagulation. Blood. 2002 Jul 1;100(1):148–52.CrossRef Google Scholar PubMed

Hartert, H. [Not Available]. Klin Wochenschr. 1948 Oct 1;26(37–38):577–83.CrossRef

Park, MS, Martini, WZ, Dubick, MA, Salinas, J, Butenas, S, Kheirabadi, BS, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma. 2009 Aug;67(2):266–75;discussion 75–6.CrossRef Google Scholar PubMed

Chitlur, M, Lusher, J. Standardization of thromboelastography: values and challenges. Semin Thromb Hemost. 2010 Oct;36(7):707–11.CrossRef Google Scholar PubMed

Chitlur, M, Sorensen, B, Rivard, GE, Young, G, Ingerslev, J, Othman, M, et al. Standardization of thromboelastography: a report from the TEG-ROTEM working group. Haemophilia. 2011 May;17(3):532–7.CrossRef Google Scholar PubMed

Herbstreit, F, Winter, EM, Peters, J, Hartmann, M. Monitoring of haemostasis in liver transplantation: comparison of laboratory based and point of care tests. Anaesthesia. 2010 Jan;65(1):44–9.CrossRef Google Scholar PubMed

De Pietri, L, Montalti, R, Begliomini, B, Scaglioni, G, Marconi, G, Reggiani, A, et al. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability?Eur J Anaesthesiol. 2010 Jul;27(7):608–16.CrossRef Google Scholar PubMed

Hvitfeldt Poulsen, L, Christiansen, K, Sorensen, B, Ingerslev, J. Whole blood thrombelastographic coagulation profiles using minimal tissue factor activation can display hypercoagulation in thrombosis-prone patients. Scand J Clin Lab Invest. 2006;66(4):329–36.CrossRef Google Scholar PubMed

Kupesiz, A, Rajpurkar, M, Warrier, I, Hollon, W, Tosun, O, Lusher, J, et al. Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography. Blood Coagul Fibrinolysis. 2010 Jun;21(4):320–4.CrossRef Google Scholar PubMed

Kupesiz, OA, Chitlur, MB, Hollon, W, Tosun, O, Thomas, R, Warrier, I, et al. Fibrinolytic parameters in children with noncatheter thrombosis: a pilot study. Blood Coagul Fibrinolysis. 2010 Jun;21(4):313–19.CrossRef Google Scholar PubMed

Kashuk, JL, Moore, EE. The emerging role of rapid thromboelastography in trauma care. J Trauma. 2009 Aug;67(2):417–18.CrossRef Google Scholar PubMed

Geerts, WH, Code, KI, Jay, RM, Chen, E, Szalai, JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994 Dec;331(24):1601–6.CrossRef Google Scholar PubMed

Watters, JM, Sambasivan, CN, Zink, K, Kremenevskiy, I, Englehart, MS, Underwood, SJ, et al. Splenectomy leads to a persistent hypercoagulable state after trauma. Am J Surg. May 2010;199(5):646–51.CrossRef Google Scholar PubMed

Copeland, H, Nolan, PE, Covington, D, Gustafson, M, Smith, R, Copeland, JG. A method for anticoagulation of children on mechanical circulatory support. Artif Organs. 2011 Nov;35(11):1018–23.CrossRef Google Scholar PubMed

Andreasen, JB, Hvas, AM, Christiansen, K, Ravn HB. Can RoTEM(R) analysis be applied for haemostatic monitoring in paediatric congenital heart surgery?Cardiol Young. 2011 Dec;21(6):684–91.CrossRef Google Scholar PubMed

Moganasundram, S, Hunt, BJ, Sykes, K, Holton, F, Parmar, K, Durward, A, et al. The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children. Anesth Analg. 2010 Apr;110(4):995–1002.Google Scholar PubMed

Holcomb, JB, Minei, KM, Scerbo, ML, Radwan, ZA, Wade, CE, Kozar, RA, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. Sep;256(3):476–86.CrossRef

Differding, JA, Underwood, SJ, Van, PY, Khaki, RA, Spoerke, NJ, Schreiber, MA. Trauma induces a hypercoagulable state that is resistant to hypothermia as measured by thromboelastogram. Am J Surg. May;201(5):587–91.

Goldenberg, NA, Hathaway, WE, Jacobson, L, Manco-Johnson, MJ. A new global assay of coagulation and fibrinolysis. Thromb Res. 2005;116(4):345–56.CrossRef Google Scholar PubMed

Antovic, A. The overall hemostasis potential: a laboratory tool for the investigation of global hemostasis. Semin Thromb Hemost. 2010 Oct;36(7):772–9.CrossRef Google Scholar PubMed

He, S, Bremme, K, Blomback, M. A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results. Thromb Res. 1999 Oct;96(2):145–56.CrossRef Google Scholar PubMed

He, S, Antovic, A, Blomback, M. A simple and rapid laboratory method for determination of haemostasis potential in plasma. II. Modifications for use in routine laboratories and research work. Thromb Res. 2001 Sep;103(5):355–61.CrossRef Google Scholar PubMed

Bombardier, C, Villalobos-Menuey, E, Ruegg, K, Hathaway, WE, Manco-Johnson, MJ, Goldenberg, NA. Monitoring hypercoagulability and hypofibrinolysis following acute venous thromboembolism in children: application of the CloFAL assay in a prospective inception cohort study. Thromb Res. 2012 Sep;130(3):343–9.CrossRef Google Scholar

Goldenberg, NA, Hathaway, WE, Jacobson, L, McFarland, K, Manco-Johnson, MJ. Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A. Haemophilia. 2006 Nov;12(6):605–14.CrossRef Google Scholar PubMed

Goldenberg, NA, Bombardier, C, Hathaway, WE, McFarland, K, Jacobson, L, Manco-Johnson, MJ. Influence of factor IX on overall plasma coagulability and fibrinolytic potential as measured by global assay: monitoring in haemophilia B. Haemophilia. 2008 Jan;14(1):68–77.Google Scholar PubMed

University of Colorado Denver. Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT). Available from: ClinicalTrials.gov (Internet). Bethesda (MD): National Library of Medicine (US). 2000- [cited 2014 Apr 7]. Available from: .

Antovic, A, Blomback, M, Sten-Linder, M, Petrini, P, Holmstrom, M, He, S. Identifying hypocoagulable states with a modified global assay of overall haemostasis potential in plasma. Blood Coagul Fibrinolysis. 2005 Nov;16(8):585–96.CrossRef Google Scholar PubMed

Antovic, JP, Yngen, M, Ostenson, CG, Antovic, A, Wallen, HN, Jorneskog, G, et al. Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications. Blood Coagul Fibrinolysis. 2003 Sep;14(6):551–6.CrossRef Google Scholar PubMed

Antovic, JP, Rafik Hamad, R, Antovic, A, Blomback, M, Bremme, K. Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?Thromb Haemost. 2002 Oct;88(4):644–7.Google Scholar PubMed

Anzej, S, Bozic, M, Antovic, A, Peternel, P, Gaspersic, N, Rot, U, et al. Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia. Thromb Res. 2007;120(1):39–46.CrossRef Google Scholar PubMed

Rooth, E, Wallen, H, Antovic, A, von Arbin, M, Kaponides, G, Wahlgren, N, et al. Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke. Blood Coagul Fibrinolysis. 2007 Jun;18(4):365–70.CrossRef Google Scholar PubMed

Antovic, A, Blomback, M, Bremme, K, Van Rooijen, M, He, S. Increased hemostasis potential persists in women with previous thromboembolism with or without APC resistance. J Thromb Haemost. 2003 Dec;1(12):2531–5.CrossRef Google Scholar PubMed

Andresen, MS, Abildgaard, U. Coagulation inhibitor potential: a study of assay variables. Thromb Res. 2005;115(6):519–26.CrossRef Google Scholar PubMed

Andresen, MS, Abildgaard, U, Liestol, S, Sandset, PM, Mowinckel, MC, Odegaard, OR, et al. The ability of three global plasma assays to recognize thrombophilia. Thromb Res. 2004;113(6):411–17.CrossRef Google Scholar PubMed

Andresen, MS, Iversen, N, Abildgaard, U. Overall haemostasis potential assays performed in thrombophilic plasma: the effect of preactivating protein C and antithrombin. Thromb Res. 2002 Dec; 108(5–6):323–8.CrossRef Google Scholar PubMed

Antovic, A, Blomback, M, Bremme, K, He, S. The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, and treatment in pregnant women with previous thromboembolism. Blood Coagul Fibrinolysis. 2002 Apr;13(3):181–6.CrossRef Google Scholar PubMed

Smith, AA, Jacobson, LJ, Miller, BI, Hathaway, WE, Manco-Johnson, MJ. A new euglobulin clot lysis assay for global fibrinolysis. Thromb Res. 2003;112(5–6): 329–37.CrossRef Google Scholar PubMed

Rijken, DC, Hoegee-de Nobel, E, Jie, AF, Atsma, DE, Schalij, MJ, Nieuwenhuizen, W. Development of a new test for the global fibrinolytic capacity in whole blood. J Thromb Haemost. 2008 Jan;6(1):151–7.CrossRef Google Scholar PubMed

Kowalski, E, Kopec, M, Niewiarowski. An evaluation of the euglobulin method for the determination of fibrinolysis. J Clin Pathol. 1959 May;12(3):215–18.CrossRef Google Scholar PubMed

Swiatkiewicz, A, Jurkowski, P, Kotschy, M, Ciecierski, M, Jawien, A. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis. Med Sci Monit. 2002 Apr;8(4):CR263–8.Google Scholar PubMed

Doig, RG, O’Malley, CJ, Dauer, R, McGrath, KM. An evaluation of 200 consecutive patients with spontaneous or recurrent thrombosis for primary hypercoagulable states. Am J Clin Pathol. 1994 Dec;102(6):797–801.CrossRef Google Scholar PubMed

Harbourne, T, O’Brien, D, Nicolaides, AN. Fibrinolytic activity in patients with idiopathic and secondary deep venous thrombosis. Thromb Res. 1991 Dec 1;64(5):543–50.CrossRef Google Scholar PubMed

Sloan, IG, Firkin, BG. Impaired fibrinolysis in patients with thrombotic or haemostatic defects. Thromb Res. 1989 Sep;55(5):559–67.CrossRef Google Scholar PubMed

Rijken, DC, Kock, EL, Guimaraes, AH, Talens, S, Murad, SD, Janssen, HL, et al. Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests. J Thromb Haemost. 2012 Oct;10(10):2116–22.CrossRef Google Scholar PubMed

van der Pas, R, de Bruin, C, Leebeek, FW, de Maat, MP, Rijken, DC, Pereira, AM, et al. The hypercoagulable state in Cushing’s disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab. 2012 Apr;97(4):1303–10.CrossRef Google Scholar

Castoldi, E, Rosing, J. Thrombin generation tests. Thromb Res. 2011 Feb;127(Suppl 3):S21–5.CrossRef Google Scholar PubMed

Macfarlane, RG, Biggs, R. A thrombin generation test: the application in haemophilia and thrombocytopenia. J Clin Pathol. 1953 Feb;6(1):3–8.CrossRef Google Scholar PubMed

Hemker, HC, Giesen, P, AlDieri, R, Regnault, V, de Smed, E, Wagenvoord, R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002 Sep–Dec;32(5–6):249–53.CrossRef Google Scholar PubMed

Hemker, HC, Al Dieri, R, De Smedt, E, Beguin, S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost. 2006 Nov;96(5):553–61.Google Scholar PubMed

Baglin, T. Using the laboratory to predict recurrent venous thrombosis. Int J Lab Hematol. 2011 Aug;33(4):333–42.CrossRef Google Scholar

Duchemin, J, Pan-Petesch, B, Arnaud, B, Blouch, MT, Abgrall, JF. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost. 2008 Apr;99(4):767–73.Google Scholar PubMed

Vanschoonbeek, K, Feijge, MA, Van Kampen, RJ, Kenis, H, Hemker, HC, Giesen, PL, et al. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost. 2004 Mar;2(3):476–84.CrossRef Google Scholar PubMed

Dielis, AW, Castoldi, E, Spronk, HM, van Oerle, R, Hamulyak, K, Ten Cate, H, et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost. 2008 Jan;6(1):125–31.CrossRef Google Scholar

Haidl, H, Cimenti, C, Leschnik, B, Zach, D, Muntean, W. Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT). Thromb Haemost. 2006 May;95(5):772–5.CrossRef Google Scholar

Fritsch, P, Kleber, M, Rosenkranz, A, Fritsch, M, Muntean, W, Mangge, H, et al. Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels. Atherosclerosis. 2010 Oct;212(2):650–5.CrossRef Google Scholar PubMed

Segers, O, van Oerle, R, Ten Cate, H, Rosing, J, Castoldi, E. Thrombin generation as an intermediate phenotype for venous thrombosis. Thromb Haemost. 2010 Jan;103(1):114–22.CrossRef Google Scholar PubMed

Rosenkranz, A, Hiden, M, Leschnik, B, Weiss, EC, Schlembach, D, Lang, U, et al. Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost. 2008 Feb;99(2):331–7.Google Scholar PubMed

Tchaikovski, SN, van Vliet, HA, Thomassen, MC, Bertina, RM, Rosendaal, FR, Sandset, PM, et al. Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography. Thromb Haemost. 2007 Dec;98(6):1350–6.CrossRef Google Scholar PubMed

Bernhard, H, Deutschmann, A, Leschnik, B, Schweintzger, S, Novak, M, Hauer, A, et al. Thrombin generation in pediatric patients with Crohn’s disease. Inflamm Bowel Dis. 2011 Nov;17(11):2333–9.CrossRef Google Scholar PubMed

Couturaud, F, Duchemin, J, Leroyer, C, Delahousse, B, Abgrall, JF, Mottier, D. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study. Thromb Haemost. 2008 Jan;99(1):223–8.Google Scholar PubMed

Lavigne-Lissalde, G, Sanchez, C, Castelli, C, Alonso, S, Mazoyer, E, Bal Dit Sollier, C, et al. Prothrombin G20210A carriers: the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels. J Thromb Haemost. 2010 May;8(5):942–9.Google Scholar

Castoldi, E, Simioni, P, Tormene, D, Thomassen, MC, Spiezia, L, Gavasso, S, et al. Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia. J Thromb Haemost. 2007 May;5(5):971–9.CrossRef Google Scholar PubMed

Alhenc-Gelas, M, Canonico, M, Picard, V. Influence of natural SERPINC1 mutations on ex vivo thrombin generation. J Thromb Haemost. 2010 Apr;8(4):845–8.CrossRef Google Scholar PubMed

Castoldi, E, Maurissen, LF, Tormene, D, Spiezia, L, Gavasso, S, Radu, C, et al. Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency. Haematologica. 2010 Sep;95(9):1563–71.CrossRef Google Scholar PubMed

Dargaud, Y, Trzeciak, MC, Bordet, JC, Ninet, J, Negrier, C. Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost. 2006 Nov;96(5):562–7.Google Scholar PubMed

Ten Cate-Hoek, AJ, Dielis, AW, Spronk, HM, van Oerle, R, Hamulyak, K, Prins, MH, et al. Thrombin generation in patients after acute deep-vein thrombosis. Thromb Haemost. 2008 Aug;100(2):240–5.Google Scholar PubMed

van Hylckama Vlieg, A, Christiansen, SC, Luddington, R, Cannegieter, SC, Rosendaal, FR, Baglin, TP. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. Br J Haematol. 2007 Sep;138(6):769–74.CrossRef Google Scholar

Tripodi, A, Legnani, C, Chantarangkul, V, Cosmi, B, Palareti, G, Mannucci, PM. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J Thromb Haemost. 2008 Aug;6(8):1327–33.CrossRef Google Scholar PubMed

Besser, M, Baglin, C, Luddington, R, van Hylckama Vlieg, A, Baglin, T. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study. J Thromb Haemost. 2008 Oct;6(10):1720–5.CrossRef Google Scholar

Hron, G, Kollars, M, Binder, BR, Eichinger, S, Kyrle, PA. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA. 2006 Jul 26;296(4):397–402.CrossRef Google Scholar PubMed

Simpson, ML, Goldenberg, NA, Jacobson, LJ, Bombardier, CG, Hathaway, WE, Manco-Johnson, MJ. Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults. Thromb Res. 2011 Apr;127(4):317–23.CrossRef Google Scholar PubMed

van Geffen, M, Loof, A, Lap, P, Boezeman, J, Laros-van Gorkom, BA, Brons, P, et al. A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis. Hematology. 2011 Nov;16(6):327–36.CrossRef Google Scholar PubMed

van Geffen, M, van Heerde, WL. Global haemostasis assays, from bench to bedside. Thromb Res. 2012 Jun;129(6):681–7.CrossRef Google Scholar PubMed

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the PDF of this chapter is currently unknown and may be updated in the future.